Subscribe to our alternative health newsletter!

Echinacea Studies, Again!: Health Blog

| | Comments (2)

diabetes

I’m not really sure why people are so enamored of peer reviewed studies. Depending on your methodology, you can get them to prove anything. We’ve had peer reviewed studies that prove hormone replacement therapy is helpful, that it’s harmful, that it works, that it doesn’t work, and that in only works for five years around menopause. If you can get a peer reviewed study to come out with continually contradicting results, how much value can it have?

Which brings us to Echinacea!

A peer reviewed study released today finds that Echinacea is effective at preventing and reversing colds. This is in total contradiction of several previous peer reviewed studies that proved it didn’t. At the time, I said the previous studies used flawed methodologies.

Is the new study using better methodology? Not necessarily, although it claims to – and claims the previous studies used flawed methodology. Although peer reviewed studies are considered the Holy Grail of medicine (I am often asked, “Where are your peer reviewed studies on alternative health treatment?”). They aren’t really that reliable. You can get them to say anything.

In the end, anecdotal evidence, especially when it comes from centuries of report, has equal validity.



Comments

According to Prof Ernst here in the UK Andrographis paniculta (known as Indian Echinacea)although less well known is more effective in 6 studies for fighting colds.
Have you heard of this and what do you think?

Posted By: Leslie Sprinkle | August 5, 2007 7:15 PM

My question is:
Why don't they do their "pick-apart" studies on the Rx's before they're released to the unsuspecting public?

Also,if natural herbs, etc. have no healing
properties and can't be trusted.....
WHY DO PHARMACEUTICAL COMPANIES DEVELOP SO
MANY SYNTHETIC HERBS & VITAMINS?????????



Post a Comment

Name:
Email Address:
URL:
Remember Personal Info?
Comments: (You may use HTML tags for style)
 
 
Contact Us | About Us | Legal Disclaimer | Content Share Program | Press Room | Site Map